NDUFB3

NDUFB3 is a nuclear-encoded accessory subunit of the membrane arm of mitochondrial Complex I (NADH:ubiquinone oxidoreductase) that is essential for proper Complex I assembly and function. Identified as a component of the hydrophobic protein fraction of Complex I (PMID:9878551), NDUFB3 was structurally resolved within the intact human respiratory megacomplex I₂III₂IV₂ by cryo-EM (PMID:28844695), and CRISPR-mediated knockout demonstrated that its loss destabilizes co-module subunits and abolishes Complex I assembly (PMID:27626371). A recurrent homozygous missense variant (p.Trp22Arg) in NDUFB3 causes a recognizable syndrome of short stature and facial dysmorphism with isolated Complex I assembly deficiency, established across multiple unrelated families (PMID:27091925).

1. 1998 Medium

   Establishing NDUFB3 as a nuclear-encoded Complex I subunit answered the question of the complete subunit composition of human Complex I, placing NDUFB3 in the hydrophobic protein fraction of the enzyme.

   Evidence cDNA cloning and sequencing of nuclear-encoded Complex I subunits from human tissue

   PMID:9878551

   Open questions at the time

   • No functional role established beyond membership in the HP fraction
   • No structural context within the intact complex
2. 2003 Medium

   Proteomic confirmation of NDUFB3 as an integral structural subunit of the immunopurified human Complex I resolved whether NDUFB3 is a stably associated component or a loosely bound factor.

   Evidence Immunocapture of intact Complex I from human tissue followed by MALDI-TOF and nanoLC-MS/MS identification

   PMID:12611891

   Open questions at the time

   • No information on NDUFB3's specific position within Complex I architecture
   • No data on whether NDUFB3 is required for Complex I assembly versus stability
3. 2012 Medium

   Identification of a pathogenic NDUFB3 mutation in a patient with isolated Complex I deficiency, rescued by complementation, established that NDUFB3 dysfunction is sufficient to cause mitochondrial disease.

   Evidence MitoExome targeted sequencing of ~1,000 mitochondrial-nuclear genes in patient cells, complementation rescue

   PMID:22277967

   Open questions at the time

   • Specific molecular mechanism of pathogenicity (assembly, stability, or catalysis) was not delineated
   • Clinical spectrum limited to a single case report
4. 2016 High

   CRISPR knockout of NDUFB3 in human cells and identification of the recurrent p.Trp22Arg variant across multiple families together established that NDUFB3 is strictly required for Complex I assembly and that its loss causes a genetically defined syndrome of short stature and facial dysmorphism with Complex I deficiency.

   Evidence CRISPR-Cas9 KO with BN-PAGE and quantitative proteomics (assembly); WES/targeted sequencing with clinical phenotyping of 10 patients from 8 families (disease)

   PMID:27091925 PMID:27626371

   Open questions at the time

   • Precise step at which NDUFB3 acts during the Complex I assembly pathway is unknown
   • Whether the p.Trp22Arg variant retains partial function or is a null allele was not resolved
5. 2017 High

   Cryo-EM structure of the human respiratory megacomplex provided the first atomic-level positional context for NDUFB3 within the membrane arm, answering where NDUFB3 sits relative to other subunits and supercomplexes.

   Evidence Cryo-electron microscopy of human megacomplex I₂III₂IV₂

   PMID:28844695

   Open questions at the time

   • No structure of a disease-mutant form of NDUFB3 to explain pathogenic mechanism
   • Functional contacts between NDUFB3 and neighboring subunits not dissected by mutagenesis
6. 2017 Low

   Detection of NDUFB3 as part of an HSC20-interacting network linked it to iron-sulfur cluster delivery during Complex I biogenesis, suggesting a previously unrecognized role in Fe-S acquisition.

   Evidence Affinity purification-mass spectrometry and co-immunoprecipitation

   PMID:28380382

   Open questions at the time

   • NDUFB3 was not the primary target; interaction identified within a broad Complex I subunit network without reciprocal validation specific to NDUFB3
   • Whether NDUFB3 directly binds HSC20 or is a bystander within the co-precipitated complex is unresolved
   • Functional consequence of disrupting NDUFB3–HSC20 interaction was not tested

• The precise assembly intermediate at which NDUFB3 is incorporated into Complex I, the structural basis for pathogenicity of the p.Trp22Arg variant, and whether NDUFB3 has any regulatory role beyond structural scaffolding remain open questions.
• No time-resolved assembly pathway data placing NDUFB3 incorporation at a defined step
• No crystal or cryo-EM structure of mutant NDUFB3 to explain p.Trp22Arg pathogenesis
• Whether NDUFB3 participates in supercomplex formation or respirasome regulation is untested